Mechanistically, IL-1β appears to mediate cholestasis in PNAC through hepatocellular NF-κB signaling, which interferes with the ability of FXR to bind to and transactivate Abcb11 and Abcc2 promoters, thus reducing canalicular bile and bilirubin transport. The gene discussed is ABCC2; the disease is cholestasis.